Life-style advice in general practice aimed at preventing cardiovascular disease;Forebyggende livsstilsråd mot hjerteog karsykdommer i primærhelsetjenesten

Tidsskrift for den Norske Laegeforening

Volumn 120, Issue 22, 2000, Pages 2656-2660

  Meland, Eivind ^a   Ellekjær, Hanne ^b   Gjelsvik, Bjørn ^b   Kimsås, Alf ^c   Holmen, Jostein ^b   Hetlevik, Irene ^b  

^a UNIVERSITY OF BERGEN   (Norway)

^b Samfunnsmedisinsk Forskningssenter ^*  (Norway)

^c Bjerke Legesenter   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; VITAMIN;

CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EXERCISE; FEEDING BEHAVIOR; HEALTH BEHAVIOR; HUMAN; LIFESTYLE; META ANALYSIS; METHODOLOGY; NORWAY; PRACTICE GUIDELINE; PRIMARY PREVENTION; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; REVIEW; SMOKING CESSATION; SOCIOECONOMICS;

ANTIOXIDANTS; CARDIOVASCULAR DISEASES; EXERCISE; FOOD HABITS; HEALTH BEHAVIOR; HUMANS; LIFE STYLE; META-ANALYSIS; NORWAY; PRACTICE GUIDELINES; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIALS; SMOKING CESSATION; SOCIOECONOMIC FACTORS; VITAMINS;

EID: 0034692302     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. Holmen J, Hetlevik I, Ellekjær H, Gjelsvik B, Kimsås A, Meland E. Kliniske retningslinjer for primærhelsetjenesten. Tidsskr Nor Lægeforen 1999; 119: 1794-9.
2. Hetlevik I, Holmen J, Ellekjær H, Gjelsvik B, Kimsås A, Meland E. Kliniske retningslinjer for hypertensjon. Tidsskr Nor Lægeforen 1999; 119: 3037-41.
3. Forland F. Retningslinjer for retningslinjer. Rapport til helsedirektøren: prosess og metode for utvikling og implementering av faglige retningslinjer. Oslo: Statens helsetilsyn, 1998.
4. Lawrence M, Neil A, Fowler G, Mant D. Prevention of cardiovascular disease. An evidence based approach. Oxford: Oxford University Press, 1996.
5. Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJ red. Evidence based cardiology. London: BMJ Books, 1998.
6. Hetlevik I. The role of clinical guidelines in cardiovascular risk intervention in general practice. Doktoravhandling. Trondheim: Institutt for samfunnsmedisinske fag, Norges teknisk-naturvitenskapelige universitet, 1999.
7. Meland E. Management of coronary heart disease risk in general practice. General practitioners' assessment of risk, and effects of life style intervention among men with high risk for coronary heart disease. Doktoravhandling. Bergen: Institutt for samfunnsmedisinske fag, Universitetet i Bergen, 1997.
8. Petersen H, Næss A-C, Dalsegg A, Lupton B, Olsen JA, Thelle D et al. Behandling av mild hypertensjon. Konsensuskonferanse. Oslo: Norges forskningsråd, Komiteen for medisinsk teknologivurdering, 1997.
9. Fowler G. Tobacco and cardiovascular disease: achieving smoking cessation. I: Yusuf S, red. Evidence based cardiology. London: BMJ Books, 1998: 179-90.
10. Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ 1989; 298: 789-94.
11. Benowitz NL. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med 1988; 319: 1318-30.
12. Meland E, Lærum E, Mæland JG. Life style intervention in general practice: effects on psychological well-being and patient satisfaction. Qual Life Res 1996; 15: 57-64.
13. Stott NCH, Pill RM. Health promotion and the human response to loss: clinical implications of a decade of primary health care research. Fam Pract 1987; 4: 278-86.
14. Doll R, Peto R. Mortality in relation to smoking: 20 years observation of British male doctors. BMJ 1976; 4: 1525-36.
15. Rose G, Colwell L. Randomised controlled trial of anti-smoking advice: final (20 year) results. J Epidemiol Community Health 1992; 46: 75-7.
16. Hjermann I, Holme I, Byre KV, Leren P. Effect of diet and smoking intervention on the incidence of coronary heart disease. Lancet 1981; 2: 1303-10.
17. Hjermann I, Holme I, Leren P. Oslo study diet and anti-smoking trial - results after 102 months. Am J Med 1986; 80 (suppl 2A): 7-11.
18. Russell MAH, Wilson C, Taylor C, Baker CD. Effect of general practitioners' advice against smoking. BMJ 1979; 2: 231-5.
19. Ashenden R, Silagy C, Weller D. A systematic review of the effectiveness of promoting life-style change in general practice. Fam Pract 1997; 14: 160-76.
20. Kottke TE, Battista RN, DeFriese GH, Brekke ML. Attributes of successful smoking cessation interventions in medical practice. Meta-analysis of 39 controlled trials. JAMA 1988; 259: 2883-9.
21. Silagy C, Lancaster T, Fowler G, Spiers I. Meta-analysis: training health care professionals to provide smoking cessation only slightly increases smoking cessation. I: Lancaster T, Silagy C, Fullerton D, red. Tobacco addiction module of the Cochrane database of systematic reviews. London: BMJ Publishing Group, 1996.
22. Silagy C, Mant D, Fowler G, Lancaster T. Nicotine replacement therapy for smoking cessation (Cochrane Review). I: The Cochrane Library, Issue 2, 1999. Oxford: Update Software) 1999.
23. Gourlay SG, Stead LF, Benowitz NL. Clonidine for smoking cessation (Cochrane Review). I: The Cochrane Library, Issue 2. Oxford: Update Software, 1999.
24. Hughes JR, Stead LF, Lancaster T. Anxiolytics and antidepressants for smoking cessation (Cochrane Review). I: The Cochrane Library, Issue 2. Oxford: Update Software, 1999.
25. Cromwell J, Bartosch WJ, Fiore MC, Hasselblad V, Baker T. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. JAMA 1997; 278: 1759-66.
26. Frost CD, Law MR, Wald NJ. By how much does dietary salt reduction lower blood pressure? II-Analysis of observational data within populations. BMJ 1991; 302: 815-8.
27. Furberg C, Psaty B, Cutler J. Blood pressure and cardiovascular disease. I: Yusuf S, Cairns J, Camm A, Fallen E, Gersh B, red. Evidence based cardiology. London: BMJ Books, 1998: 226-38.
28. Ravnskov U. The questionable role of saturated and polyunsaturated fatty acids in cardiovascular disease. J Clin Epidemiol 1998; 51: 443-60.
29. Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? III-Analysis of data from trials of salt reduction. BMJ 1991; 302: 819-24.
30. Meland E, Lærum E, Aakvaag A, Ulvik R, Høstmark A. Salt restriction: effects on lipids and insulin production in hypertensive patients. Scand J Clin Lab Invest 1997; 57: 501-6.
31. Stamler R, Stamler J, Grimm R, Gosch FC, Elmer P, Dyer A et al. Nutritional therapy for high blood pressure. Final report of a four-year randomized controlled trial - The hypertension control program. JAMA 1987; 257: 1484-91.
32. Fagerberg B, Berglund A, Andersson OK, Berglund G. Weight reduction versus antihypertensive drug therapy in obese men with high blood pressure: effects upon plasma insulin levels and association with changes in blood pressure and serum lipids. J Hypertens 1992; 10: 1053-61.
33. Garber A, Browner W, Hulley S. Cholesterol screening in asymptomatic adults, revisited. Ann Intern Med 1996; 124: 515-7.
34. Burr ML, Gilbert JF, Holliday RM, Elwood PC, Fehily AM, Rogers S et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and reinfarction trial (DART). Lancet 1989; 2: 757-61.
35. Christensen JH, Gustenhoff P, Korup E, Aarøe J, Toft E, Møller JM et al. n-3 polyumættede fedtsyrer, hjertefrekvensvariabilitet og ventrikulære arytmier hos post-AMI-patienter. Et klinisk kontrolleret studie. Ugeskr Læger 1997; 159: 5525-9.
36. Bønaa KH, Bjerve KS, Straume B, Gram IT, Thelle D. Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. A population based intervention trial from the Tromsø Study. N Engl J Med 1990; 322: 795-801.
37. DeLorgeril M, Salen P, Martin J-L, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction. Final report of the Lyon Diet Heart Study. Circulation 1999; 99: 779-85.
38. Singh RB, Rastogi SS, Verma R, Laxmi B, Singh R, Ghosh S et al. Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up. BMJ 1992; 304: 1015-9.
39. Mant D, Little P. Exercise. I: Lawrence M, Neil A, Fowler G, Mant D, red. Prevention of cardiovascular disease. An evidence based approach. Oxford: Oxford University Press, 1996: 67-80.
40. Froelicher ES, Oka OK, Fletcher GF. Physical activity and exercise in cardiovascular disease prevention and rehabilitation. I: Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJ, red. Evidence based cardiology. London: BMJ Books, 1998: 251-68.
41. Anderssen SA. The Oslo Diet and Exercise Study. Effect of diet and exercise upon risk factors for cardiovascular disease. A one year randomized controlled study. Oslo: Norges idrettshøgskole, 1996.
42. Smith JK, Dykes R, Douglas JE, Krishnaswamy G, Berk S. Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. JAMA 1999; 281: 1722-7.
43. Kokkinos PF, Narayan P, Colleran JA, Pittaras A, Notargiacomo A, Reda D et al. Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension. N Engl J Med 1995; 333: 1462-7.
44. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-94.
45. Richelsen B. Health risks of obesity. Significance of the regional distribution of adipose tissue. Ugeskr Læger 1991; 153: 908-12.
46. Brand MB, Mulrow CD, Chiquette E, Angel L, Cornell J, Summerbell C et al. Dieting to reduce body weight for controlling hypertension in adults (Cochrane Review). I: The Cochrane Library, Issue 2, 1999. Oxford: Update Software.
47. Wood PD, Stefanick ML, Dreon DM, Frey-Hewitt B, Garay SC, Williams PT et al. Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. N Engl J Med 1988; 319: 1173-9.
48. Andersen E, Grimsmo A. Langtidsresultater ved slanking i selvhjelpsgrupper. Tidsskr Nor Lægeforen 1999; 119: 14-7.
49. Brown S, Upchurch S, Anding R, Winter M, Ramirez G. Promoting weight loss in type II diabetes. Diabetes Care 1996; 19: 613-24.
50. Anderson P, Alcohol. I: Lawrence M, Neil A, Fowler G, Mant D, red. Prevention of cardiovascular disease. Oxford: Oxford University Press, 1996: 81-92.
51. Hendriks H, Veenstra J, Velthuis-teWierik E, Schaafsma G, Kluft C. Effect of moderate dose of alcohol with evening meal on fibrinolytic factors. BMJ 1994; 308: 1003-6.
52. Gaziano J, Buring J, Breslow J, Goldhaber SZ, Rosner B, VanDenburgh M et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med 1993; 329: 1829-34.
53. Valmadrid C, Klein R, Moss S, Klein B, Cruickshanks K. Alcohol intake and the risk of coronary heart disase mortality in persons with older-onset diabetes mellitus. JAMA 1999; 282: 239-46.
54. Hein H, Suadicani P, Gyntelberg F. Alcohol consumption, serum low density lipoprotein cholesterol concentration, and risk of ischemic heart disease: six year follow up in the Copenhagen male study. BMJ 1996; 312: 736-41.
55. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999; 99: 2192-217.
56. Hemingway H, Marmot M. Psychosocial factors in the primary and secondary prevention of coronary heart disease: a systematic review. I: Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJ, red. Evidence based cardiology. London: BMJ Books, 1998: 269-85.
57. Linden W, Stossel C, Maurice J. Psychosocial interventions for patients with coronary artery disease: a meta-analysis. Arch Intern Med 1996; 156: 745-52.
58. Lonn E, Yusuf S. Emerging approaches in cardiovascular prevention. I: Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJ, red. Evidence based cardiology. London: BMJ Books, 1998: 286-302.
59. Tonstad S. Antioksidanter og hjerte- og karsykdom - epidemiologiske aspekter. Bør tilskudd anbefales for høyrisikopasienter? Tidsskr Nor Lægeforen 1995; 115: 227-9.
60. Stephens N, Parsons A, Schofield P, Kelly F, Cheeseman K, Mitchenson MJ et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge heart antioxidant study (CHAOS). Lancet 1996; 347: 781-6.
61. Tell GS, Vollset SE, Lande B, Pedersen JI, Løken EB, Jacobsen BK. Folat og helse - ny kunnskap og nye anbefalinger. Tidsskr Nor Lægeforen 1998; 118: 3155-60.
62. Nappo F, DeRosa N, Marfella R, DeLucia D, Ingrosso D, Perna AF et al. Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. JAMA 1999; 281: 2113-8.
63. Stewart M, Brown JB, Weston WW, McWhinney IR, McWilliam CL, Freeman TR. Patient-centered medicine. Transforming the clinical method. Thousand Oaks: Sage Publications, 1995.
64. Bass MJ, Buck C, Turner L, Dickie G, Pratt G, Robinson C. The physician's actions and the outcome of illness in family practice. J Fam Pract 1986; 23: 43-7.
65. The Headache Study Group of the University of Western Ontario. Predictors of outcome in headache patients presenting to family physicians - a one year prospective study. Headache 1986; 26: 285-94.
66. Henbest RJ, Stewart MA. Patient-centredness in the consultation. 2: Does it really make a difference? Fam Pract 1990; 7: 28-33.
67. Ockene JK, Kristeller J, Goldberg R, Amick TL, Pekow PS, Hosmer D et al. Increasing the efficacy of physician-delivered smoking interventions: a randomized clinical trial. J Gen Intern Med 1991; 6: 1-8.
68. Kinmonth A, Woodcock A, Griffin S, Spiegal N, Campbell M. Randomised controlled trial of patient centred care of diabetes in general practice: impact on current wellbeing and future disease risk. BMJ 1998; 317: 1202-8.
69. Mazzuca SA. Does patient education in chronic disease have therapeutic value. J Chron Dis 1982; 35: 521-9.
70. Law M, Tang J. An analysis of the effectiveness of interventions intended to help people stop smoking. Arch Intern Med 1995; 155: 1933-41.
71. Glanz K, Lewis FM, Rimer BK. Health behaviour and health education. Theory, research and practice. San Francisco - Oxford: Jossey-Bass Publishers, 1990.
72. Deci EL, Ryan RM. Intrinsic motivation and self-determination in human behavior. New York: Plenum Press, 1985.
73. Harackiewics J, Sansone C, Blair L, Epstein J, Manderlink G. Attributional processes in behavior change and maintenance: Smoking cessation and continued abstinence. J Consult Clin Psychol 1987; 55: 372-8.
74. Curry SJ, Wagner EH, Grothaus LC. Evaluation of intrinsic and extrinsic motivation interventions with a self-help smoking cessation program. J Consult Clin Psychol 1991; 59: 318-24.
75. Stott NCH, Pill RM. «Advise yes, dictate no». Patients' views on health promotion in the consultation. Fam Pract 1990; 7: 125-31.
76. Orlinsky DE, Grawe K, Parks PK. Process and outcome in psychotherapy - noch einmal. I: Bergin AE, Garfield SL, red. Handbook of psychotherapy and behavior change. New York: Wiley, 1994: 270-367.